This difference in IL12-MSA binding was observed only in the TdLN, but not the spleen or tumor, consistent with our observation that SIY-reactive CD8+ T cell activation occurred mostly in KP.SIY flank TdLNs after IL12-MSA administration (Figure 1, C–G). This evidence concerns the gene CD8A and neoplasm.